Research ArticleMolecular Imaging
Direct Imaging of Drug Distribution and Target Engagement of the PARP Inhibitor Rucaparib
Susanne Kossatz, Brandon Carney, Christopher Farley, Wolfgang A. Weber, Charles M. Drain and Thomas Reiner
Journal of Nuclear Medicine August 2018, 59 (8) 1316-1320; DOI: https://doi.org/10.2967/jnumed.117.205765
Susanne Kossatz
1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
Brandon Carney
1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
2Hunter College and Graduate Center of the City University of New York, New York, New York
Christopher Farley
2Hunter College and Graduate Center of the City University of New York, New York, New York
Wolfgang A. Weber
1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
3Department of Radiology, Weill Cornell Medical College, New York, New York; and
4Department of Nuclear Medicine, Technical University Munich, Munich, Germany
Charles M. Drain
2Hunter College and Graduate Center of the City University of New York, New York, New York
Thomas Reiner
1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
3Department of Radiology, Weill Cornell Medical College, New York, New York; and

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 59, Issue 8
August 1, 2018
Direct Imaging of Drug Distribution and Target Engagement of the PARP Inhibitor Rucaparib
Susanne Kossatz, Brandon Carney, Christopher Farley, Wolfgang A. Weber, Charles M. Drain, Thomas Reiner
Journal of Nuclear Medicine Aug 2018, 59 (8) 1316-1320; DOI: 10.2967/jnumed.117.205765